Kantonsspital St.Gallen
anmelden

Publikationen

Stefanie Müller

Titel  
 
Hasan A, Berner F, Ackermann C J, Ring S, Moulin A, Müller J, Markert E, Pop O, Müller S, Diem S, Hundsberger T, Flatz L. Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunol Immunother 2020; 70:563-568.
   
Heckmann J, Todorova M, Müller S, Broser P J, Sturm V. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis. Klin Monbl Augenheilkd. 2020;.
   
Müller S, Vehoff J. Aktuelle Therapien der Multiplen Sklerose. der informierte @rzt 2019; Vol. 9:26-27.
   
uffer d, Müller S, Vehoff J. Multiple Sklerose: Neues zur monoklonalen Antikörpertherapie. InFo NEUROLOGIE & PSYCHIATRIE 2018; 1:15-18.
   
Kamm C P, Muehl S, Mircsof D, Müller S, Czaplinski A, Achtnichts L, Stellmes P, Di Virgilio G. Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey. Front Neurol 2018; 9:821.
   
Pardini M, Botzkowski D, Müller S, Vehoff J, Kuhle J, Ruberte E, Würfel J, Gass A, Valmaggia C, Tettenborn B, Putzki N, Yaldizli . The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography. Eur J Neurol 2016;.
   
Disanto G, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E W, Sprenger T, Stippich C, Derfuss T, Louvion J F, Kamm C P, Mattle H P, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P H, Yaldizli , Gobbi C, Kappos L, Kuhle J, . The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS ONE 2016; 11:e0152347.
   
Müller S. Behandlung eines Multiple-Sklerose-Schubs - Orale versus intravenöse Steroide. InFo NEUROLOGIE & PSYCHIATRIE 2015; Vol. 14, Nr. 1 2015; Vol. 14:5-5.
   
Engeler D S, Meyer D, Abt D, Müller S, Schmid H P. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol 2015; 15:105.
   
Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M. Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies. Eur Neurol 2013; 70:35-41.
   
Vehoff J, Müller S, Tettenborn B. Multiple Sklerose: Neue Diagnosekriterien und neue Therapiemöglichkeiten. InFo Neurologie & Psychiatrie 2011; Vol.9:.
   
Hundsberger T, Müller S, Sommacal A, Fretz C, Tettenborn B. Koinzidenz von ischämischer Enzephalopathie und essentieller Thrombozythämie: zerebrale kortikale Venenthrombose ?. Schweizer Archiv für Neurologie und Psychiatrie 2010; 161:262-265.
   
Müller S, Schött D, Altland K, Tettenborn B. Hereditary transthyretin amyloidosis: a case report of a newly described TTR variant Ile 107 Met. Schweiz Arch Neurol Psych 2004; 155:91-92.
   
Vehoff J ; Hägele-Link S ; Humm A ; Müller S ; sauter r ; Tettenborn B ; Hundsberger T: Heart rate variability decreases after 3 months of sustained treatment with fingolimod in patients with multiple sclerosis: a prospective clinical trial. In: Session PRS2102 Autonomic nervous system 2 : EAN, 2017.- 3rd EAN Congress.- Amsterdam, S. 2013
   
Muehl S ; Czaplinski A ; Stelmess P ; Kamm C P ; Müller S ; Muehl S: Role of family planning in women of child-bearing age with multiple sclerosis (MS) in Switzerland: Results of the Women. In : keiner, 2016.- American Academy of Neurology AAN.- Vancouver, B.C: Canada, AAN, 15–21 April 2016, Abstract No. 1735, S. 1
   
Pardini M ; Botzkowski D ; Müller S ; Vehoff J ; Kuhle J ; Gass A ; Würfel J ; Valmaggia C ; Tettenborn B ; Putzki N ; Yaldizli : Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study. In: P1004 : kein, 2015.- ECTRIMS 2015.- Barcelona, S. 1
   
prochnicki a ; Zieglgänsberger D ; Vehoff J ; Müller S ; Tettenborn B ; Hundsberger T: Glioblastoma multiforme: Chameleon of neurology A case report. In, 2015.- SNG Tagung 2015.- Bern, S. 1
   
Disanto G ; Benkert P ; Lohrscheider J ; Müller S ; Vehoff J ; Zecca C ; Ramseier S ; Achnichts L ; Findling O ; Nedeltchev K ; Radue E ; Sprenger T ; Stippich C ; Derfuss T ; Louvion J F ; Kamm C ; Mattle H ; Lotter C ; du Pasquier R ; Schluepp M ; Pot C ; Lalive P ; Kappos L ; Kuhle J: The Swiss multiple sclerosis cohort study: a prospective nationwide investigation of disease evolution and the effects of new disease modifying drugs. In: P775 : keiner, 2015.- ECTRIMS 2015.- Barcelona, Spanien, S. 1
   
Döhler N ; Müller S ; Vehoff J ; galovic m ; Tettenborn B: Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab. In: P327 : keiner, 2014.- ECTRIMS 2014.- Boston, Massachusetts, USA, S. 1
   
yildiz m ; Müller S ; Vehoff J ; Tettenborn B: Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate: 1 year follow-up. In: P03.225 : keiner, 2011.- AAN.- Honolulu, Hawaii, USA, S. 1
   
Müller S ; Bönig L ; von Manitius S ; Weder B ; Tettenborn B: Abnormal sleep/wake-patterns in. 173. Tagung der Schweizerischen Neurologischen Gesellschaft in Luzern, 2009
   
Vehoff J ; Müller S: Spontaneous internal carotid artery dissection presenting as hypoglossal nerve palsy. Gemeinsame Jahrestagung Schweizerische Neurologische Gesellschaft SNG (182. Tagung). Interlaken, 2009
   
Müller S ; Endress E ; Schött D ; Hägele-Link S: Anti-Hu syndrome preceding a carcinoma of the vocal cords. 177. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken), 2006
   
Müller S ; Endress E ; Schött D ; Hägele-Link S ; Tettenborn B: Anti-Hu syndrome preceding a carcinoma of the vocal cords. 177. Tagung Schweiz. Neurologischen Gesellschaft. Interlaken, 2006
   
Müller S ; Tettenborn B ; Bönig L: Wound botulism in an injection drug user. 176. Tagung der Schweizerischen Neurologischen Gesellschaft (St. Gallen), 2005
   
Müller S ; Tettenborn B ; Schött D ; Altland K: Hereditary transthyretin amyloidosis:a case report of a newly described TTR variant Ile 107Met. 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken). 172. Tagung der Schweizerischen Neurologischen Gesellschaft (Interlaken), 2004
   
Müller S ; Schött D ; Altland K ; Tettenborn B: Hereditary transthyretin amyloidosis: a case report of a newly described TTR variant Ile 107 Met. Joint Meeting of the Swiss Society for Neurology (SNG) and the Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SGSSC). Zürich, 2003
   
 
Seite 1 von 1